AUPH vs EIX
Aurinia Pharmaceuticals Inc (AUPH) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AUPH revenue for 2024-12-31 was $59.9M. Net income was $1.4M. Revenue was down 11.7% from 2024-09-30 to 2024-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AUPH and EIX stock pages for the full models.
Not investment advice.